MOTRIN PLATINUM MUSCLE & BODY 200 MG
IBUPROFEN : 200 MG METHOCARBAMOL : 500 MG · DIN 02418967 · MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Health Canada status: MARKETED
What is MOTRIN PLATINUM MUSCLE & BODY?
MOTRIN PLATINUM MUSCLE & BODY 200 MG contains IBUPROFEN : 200 MG METHOCARBAMOL : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02418967, held by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 26-Feb-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is MOTRIN PLATINUM MUSCLE & BODY used for?
Effective relief of pain associated with muscle spasm such as back pain, tense neck muscles, strains and sprains.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02418967 |
|---|---|
| Brand name | MOTRIN PLATINUM MUSCLE & BODY |
| Generic / active ingredient | IBUPROFEN : 200 MG METHOCARBAMOL : 500 MG |
| Manufacturer | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M03BA53 METHOCARBAMOL, COMBINATIONS EXCL PSYCHOLEPTICS |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 26-Feb-2026 |
How is it administered?
Adults and Children over 12: 1 to 2 caplets every 4-6 hours. Do not exceed 6 caplets in 24 hours unless recommended by a physician. Use lowest effective dose for shortest duration.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly stated in provided text (Section 11 referenced but content not shown). Typical for this class is 15-30°C.
How is it supplied?
Blisters of 18 and bottles of 40 caplets.
Contraindications
Hypersensitivity to ingredients; active peptic ulcer/GI disease; severe hepatic/renal impairment; asthma/allergic reactions to ASA/NSAIDs; SLE; third trimester pregnancy; peri-operative heart surgery.
Warnings and precautions
Serious GI toxicity (bleeding/ulceration); increased risk of CV thrombotic events (MI/stroke); fluid retention/edema; potential for drowsiness/dizziness; risk of aseptic meningitis in SLE.
What can be used instead?
Other Canadian products sharing ATC code M03BA53 METHOCARBAMOL, COMBINATIONS EXCL PSYCHOLEPTICS. 13 of 68 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| EXTRA STRENGTH MUSCLE & BACK PAIN ASA 500 MG METHOCARBAMOL 400 MG & ACETYLSALICYLIC ACID 500 MG | 400 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02252228 |
| EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02239141 |
| EXTRA STRENGTH MUSCLE & BACK PAIN RELIEF WITH ASA | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02426625 |
| EXTRA STRENGTH TYLENOL BACK PAIN | 400 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02290510 |
| EXTRA STRENGTH TYLENOL BODY PAIN NIGHT | 500 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02357356 |
| MUSCLE & BACK PAIN RELIEF CAPLETS | 325 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02230790 |
| MUSCLE AND BACK PAIN PLATINUM RELIEF | 200 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02422042 |
| MUSCLE AND BACK PAIN RELIEF | 500 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02451298 |
| ROBAX PLATINUM | 500 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02247147 |
| ROBAXACET | 325 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02026805 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.